159 related articles for article (PubMed ID: 25694611)
21. Carcinogenicity, metabolism and Ki-ras proto-oncogene activation by 7,12-dimethylbenz[a]anthracene in rainbow trout embryos.
Fong AT; Dashwood RH; Cheng R; Mathews C; Ford B; Hendricks JD; Bailey GS
Carcinogenesis; 1993 Apr; 14(4):629-35. PubMed ID: 8472326
[TBL] [Abstract][Full Text] [Related]
22. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
[TBL] [Abstract][Full Text] [Related]
23. Regulation of p21/ras protein expression by diallyl sulfide in DMBA induced neoplastic changes in mouse skin.
Arora A; Kalra N; Shukla Y
Cancer Lett; 2006 Oct; 242(1):28-36. PubMed ID: 16448747
[TBL] [Abstract][Full Text] [Related]
24. Metallothionein deficiency enhances skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate in metallothionein-null mice.
Suzuki JS; Nishimura N; Zhang B; Nakatsuru Y; Kobayashi S; Satoh M; Tohyama C
Carcinogenesis; 2003 Jun; 24(6):1123-32. PubMed ID: 12807749
[TBL] [Abstract][Full Text] [Related]
25. Mutually exclusive mutations of the Pten and ras pathways in skin tumor progression.
Mao JH; To MD; Perez-Losada J; Wu D; Del Rosario R; Balmain A
Genes Dev; 2004 Aug; 18(15):1800-5. PubMed ID: 15289454
[TBL] [Abstract][Full Text] [Related]
26. Methylation of the O6-methylguanine-DNA methyltransferase promoter suppresses expression in mouse skin tumors and varies with the tumor induction protocol.
Abdel-Fattah R; Glick A; Rehman I; Maiberger P; Hennings H
Int J Cancer; 2006 Feb; 118(3):527-31. PubMed ID: 16094607
[TBL] [Abstract][Full Text] [Related]
27. Protective role of Toll-like receptor 4 during the initiation stage of cutaneous chemical carcinogenesis.
Yusuf N; Nasti TH; Long JA; Naseemuddin M; Lucas AP; Xu H; Elmets CA
Cancer Res; 2008 Jan; 68(2):615-22. PubMed ID: 18199559
[TBL] [Abstract][Full Text] [Related]
28. HLA-A3 restricted mutant ras specific cytotoxic T-lymphocytes induced by vaccination with T-helper epitopes.
Gjertsen MK; Saeterdal I; Saebøe-Larssen S; Gaudernack G
J Mol Med (Berl); 2003 Jan; 81(1):43-50. PubMed ID: 12545248
[TBL] [Abstract][Full Text] [Related]
29. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
30. Haploinsufficiency of the cdc2l gene contributes to skin cancer development in mice.
Chandramouli A; Shi J; Feng Y; Holubec H; Shanas RM; Bhattacharyya AK; Zheng W; Nelson MA
Carcinogenesis; 2007 Sep; 28(9):2028-35. PubMed ID: 17389615
[TBL] [Abstract][Full Text] [Related]
31. Oncogene involvement in tumor regression: H-ras activation in the rabbit keratoacanthoma model.
Corominas M; Leon J; Kamino H; Cruz-Alvarez M; Novick SC; Pellicer A
Oncogene; 1991 Apr; 6(4):645-51. PubMed ID: 1840681
[TBL] [Abstract][Full Text] [Related]
32. Evidence that error-prone DNA repair converts dibenzo[a,l]pyrene-induced depurinating lesions into mutations: formation, clonal proliferation and regression of initiated cells carrying H-ras oncogene mutations in early preneoplasia.
Chakravarti D; Mailander PC; Cavalieri EL; Rogan EG
Mutat Res; 2000 Nov; 456(1-2):17-32. PubMed ID: 11087892
[TBL] [Abstract][Full Text] [Related]
33. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
[TBL] [Abstract][Full Text] [Related]
34. The specific N-ras mutation in rat 7,12-dimethylbenz[a]anthracene (DMBA)-induced leukemia.
Osaka M; Koh T; Matsuo S; Sugiyama T
Leukemia; 1997 Apr; 11 Suppl 3():393-5. PubMed ID: 9209402
[TBL] [Abstract][Full Text] [Related]
35. Codon 61 mutations in the c-Harvey-ras gene in mouse skin tumors induced by 7,12-dimethylbenz[a]anthracene plus okadaic acid class tumor promoters.
Fujiki H; Suganuma M; Yoshizawa S; Kanazawa H; Sugimura T; Manam S; Kahn SM; Jiang W; Hoshina S; Weinstein IB
Mol Carcinog; 1989; 2(4):184-7. PubMed ID: 2508660
[TBL] [Abstract][Full Text] [Related]
36. Induction of skin papillomas, carcinomas, and sarcomas in mice in which the connexin 43 gene is heterologously deleted.
Yamakage K; Omori Y; Zaidan-Dagli ML; Cros MP; Yamasaki H
J Invest Dermatol; 2000 Feb; 114(2):289-94. PubMed ID: 10651988
[TBL] [Abstract][Full Text] [Related]
37. Activation of the Ha-, Ki-, and N-ras genes in chemically induced liver tumors from CD-1 mice.
Manam S; Storer RD; Prahalada S; Leander KR; Kraynak AR; Ledwith BJ; van Zwieten MJ; Bradley MO; Nichols WW
Cancer Res; 1992 Jun; 52(12):3347-52. PubMed ID: 1596892
[TBL] [Abstract][Full Text] [Related]
38. Susceptibility to the biological effects of polyaromatic hydrocarbons is influenced by genes of the major histocompatibility complex.
Elmets CA; Athar M; Tubesing KA; Rothaupt D; Xu H; Mukhtar H
Proc Natl Acad Sci U S A; 1998 Dec; 95(25):14915-9. PubMed ID: 9843990
[TBL] [Abstract][Full Text] [Related]
39. Ras mutation promotes p53 activation and apoptosis of skin keratinocytes.
Zhao Y; Chaiswing L; Bakthavatchalu V; Oberley TD; St Clair DK
Carcinogenesis; 2006 Aug; 27(8):1692-8. PubMed ID: 16613839
[TBL] [Abstract][Full Text] [Related]
40. Non-melanoma skin cancer in mouse and man.
Schwarz M; Münzel PA; Braeuning A
Arch Toxicol; 2013 May; 87(5):783-98. PubMed ID: 23266722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
